KETOCONAZOLE FOAM

KETOCONAZOLE FOAM was reported 15122 times

KETOCONAZOLE FOAM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PURPURA SENILE 12 0.0984
1 TARSAL TUNNEL SYNDROME 12 0.0545
2 SEBORRHOEIC DERMATITIS 82 0.0496
3 INTERTRIGO 27 0.0495
4 ASPERGILLUS TEST POSITIVE 15 0.0487
5 CORTISOL INCREASED 30 0.0480
6 TINEA VERSICOLOUR 12 0.0333
7 LENTIGO 14 0.0282
8 TINEA CRURIS 12 0.0241
9 DANDRUFF 52 0.0235
10 BODY TINEA 13 0.0232
11 OTITIS MEDIA ACUTE 16 0.0217
12 SEBORRHOEIC KERATOSIS 31 0.0213
13 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 22 0.0207
14 HYPERPARATHYROIDISM SECONDARY 49 0.0195
15 NEPHROGENIC ANAEMIA 86 0.0185
16 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 16 0.0173
17 XEROSIS 21 0.0170
18 PNEUMONIA MYCOPLASMAL 13 0.0163
19 TINEA PEDIS 24 0.0150
20 RESORPTION BONE INCREASED 11 0.0134
21 GUTTATE PSORIASIS 11 0.0134
22 ADRENAL SUPPRESSION 11 0.0130
23 JAW FRACTURE 28 0.0130
24 IMPETIGO 19 0.0127
25 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 32 0.0120
26 CONTRAINDICATION TO MEDICAL TREATMENT 18 0.0118
27 VESTIBULAR DISORDER 14 0.0114
28 BONE DEMINERALISATION 12 0.0113
29 ACTINIC KERATOSIS 28 0.0108
30 PUSTULE 25 0.0105
31 PULMONARY GRANULOMA 12 0.0105
32 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 12 0.0100
33 REBOUND ACID HYPERSECRETION 30 0.0099
34 HYPOGONADISM 10 0.0099
35 VERTIGO POSITIONAL 17 0.0097
36 CHEMICAL BURN 11 0.0095
37 TRICHORRHEXIS 25 0.0090
38 PAPULE 62 0.0088
39 FUNGAL SKIN INFECTION 35 0.0087
40 OBSTRUCTIVE SLEEP APNOEA SYNDROME 12 0.0082
41 HAIR TEXTURE ABNORMAL 105 0.0078
42 DEAFNESS BILATERAL 13 0.0076
43 END STAGE RENAL DISEASE 136 0.0074
44 AORTIC ARTERIOSCLEROSIS 19 0.0074
45 CRYPTOCOCCOSIS 12 0.0074
46 PRODUCT ADMINISTRATION INTERRUPTED 57 0.0073
47 PROSTATE CANCER METASTATIC 24 0.0072
48 SKIN PAPILLOMA 27 0.0067
49 SKIN WEEPING 24 0.0067
50 BLOOD IMMUNOGLOBULIN E INCREASED 16 0.0066
51 ESSENTIAL HYPERTENSION 12 0.0066
52 CHEST X-RAY ABNORMAL 20 0.0065
53 SKIN PLAQUE 55 0.0065
54 ADRENAL INSUFFICIENCY 79 0.0065
55 ECONOMIC PROBLEM 98 0.0065
56 CHRONIC KIDNEY DISEASE 488 0.0064
57 DERMATITIS PSORIASIFORM 13 0.0064
58 MELANOCYTIC NAEVUS 27 0.0062
59 ADRENOCORTICAL INSUFFICIENCY ACUTE 12 0.0061
60 BLOOD CHLORIDE DECREASED 15 0.0058
61 PRE-EXISTING CONDITION IMPROVED 36 0.0058
62 ANHEDONIA 151 0.0057
63 PROSTATIC SPECIFIC ANTIGEN INCREASED 79 0.0057
64 THROMBOPHLEBITIS SUPERFICIAL 17 0.0056
65 ROSACEA 26 0.0056
66 NOSOCOMIAL INFECTION 12 0.0054
67 RHINITIS ALLERGIC 24 0.0054
68 BACTERIAL TEST POSITIVE 12 0.0054
69 MIXED LIVER INJURY 16 0.0053
70 HAIR COLOUR CHANGES 65 0.0052
71 MACULE 14 0.0050
72 CLOSTRIDIUM TEST POSITIVE 11 0.0050
73 SKIN HYPERTROPHY 14 0.0050
74 LIP PAIN 14 0.0049
75 OTITIS MEDIA 16 0.0048
76 LUMBAR SPINAL STENOSIS 14 0.0048
77 OSTEITIS 12 0.0048
78 PSORIASIS 612 0.0047
79 PRURITUS GENITAL 11 0.0047
80 LOOSE TOOTH 15 0.0047
81 LUNG CONSOLIDATION 13 0.0046
82 SEBORRHOEA 17 0.0046
83 LEG AMPUTATION 19 0.0046
84 SCAB 52 0.0046
85 DERMAL CYST 11 0.0045
86 MYCOBACTERIUM AVIUM COMPLEX INFECTION 12 0.0045
87 BENIGN PROSTATIC HYPERPLASIA 23 0.0044
88 IDIOPATHIC INTRACRANIAL HYPERTENSION 10 0.0044
89 DERMATITIS 93 0.0044
90 BONE LESION 16 0.0044
91 HEPATITIS FULMINANT 13 0.0044
92 HYPERKERATOSIS 24 0.0043
93 SPINAL OSTEOARTHRITIS 38 0.0043
94 BLOOD CREATININE DECREASED 13 0.0041
95 HEPATOSPLENOMEGALY 10 0.0039
96 THERAPEUTIC PRODUCT INEFFECTIVE 15 0.0039
97 ONYCHOMYCOSIS 17 0.0039
98 HYPERLIPIDAEMIA 46 0.0038
99 DIVERTICULUM 27 0.0038
100 SKIN EXFOLIATION 320 0.0038
101 SLEEP APNOEA SYNDROME 72 0.0038
102 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 64 0.0038
103 OSTEOPENIA 57 0.0038
104 CHRONIC SINUSITIS 14 0.0037
105 DERMATITIS CONTACT 42 0.0037
106 DERMATITIS ATOPIC 194 0.0037
107 SWELLING OF EYELID 23 0.0037
108 NORMOCHROMIC NORMOCYTIC ANAEMIA 11 0.0037
109 SKIN INFECTION 41 0.0037
110 SPUTUM DISCOLOURED 34 0.0036
111 METASTASES TO SPINE 12 0.0036
112 RENAL TUBULAR NECROSIS 35 0.0036
113 HERPES VIRUS INFECTION 20 0.0035
114 PRODUCT PHYSICAL CONSISTENCY ISSUE 19 0.0034
115 FUNGAL INFECTION 113 0.0034
116 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 186 0.0034
117 SKIN ABRASION 16 0.0034
118 INFUSION SITE HAEMORRHAGE 11 0.0033
119 GINGIVITIS 18 0.0033
120 SKIN MASS 22 0.0033
121 VITAMIN D DEFICIENCY 32 0.0033
122 PURULENT DISCHARGE 14 0.0033
123 SKIN HYPERPIGMENTATION 28 0.0033
124 PRODUCT LABEL ISSUE 22 0.0032
125 DIASTOLIC DYSFUNCTION 10 0.0032
126 SKIN HAEMORRHAGE 48 0.0032
127 DIABETIC NEUROPATHY 16 0.0032
128 PSORIATIC ARTHROPATHY 131 0.0032
129 BRADYKINESIA 19 0.0032
130 SPINAL FUSION SURGERY 13 0.0032
131 PERIORBITAL SWELLING 18 0.0032
132 HIDRADENITIS 29 0.0032
133 SEASONAL ALLERGY 45 0.0032
134 RENAL CYST 25 0.0031
135 INTERVERTEBRAL DISC DEGENERATION 29 0.0031
136 SUBCUTANEOUS ABSCESS 15 0.0031
137 NAIL DISORDER 27 0.0031
138 SINUS DISORDER 61 0.0031
139 PIGMENTATION DISORDER 19 0.0031
140 SKIN LESION 84 0.0031
141 ABSCESS LIMB 13 0.0030
142 UPPER-AIRWAY COUGH SYNDROME 25 0.0030
143 SKIN IRRITATION 138 0.0030
144 ECZEMA 156 0.0030
145 NEURODERMATITIS 11 0.0030
146 RENAL FAILURE 392 0.0029
147 APPLICATION SITE DRYNESS 10 0.0029
148 MULTIPLE ALLERGIES 23 0.0029
149 AFFECTIVE DISORDER 23 0.0029
150 JAW DISORDER 16 0.0029
151 HEPATOTOXICITY 65 0.0029
152 SKIN FISSURES 57 0.0029
153 HYPERTRIGLYCERIDAEMIA 17 0.0029
154 FAILURE TO THRIVE 15 0.0029
155 SKIN SWELLING 25 0.0029
156 TENDERNESS 30 0.0029
157 ARTERIOSCLEROSIS CORONARY ARTERY 19 0.0029
158 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 200 0.0028
159 PROSTATOMEGALY 11 0.0028
160 SKIN DISORDER 93 0.0028
161 PERFORMANCE STATUS DECREASED 13 0.0028
162 SCRATCH 29 0.0027
163 SCOLIOSIS 17 0.0027
164 CYSTITIS HAEMORRHAGIC 11 0.0027
165 IMPAIRED GASTRIC EMPTYING 37 0.0027
166 NEPHROPATHY 25 0.0027
167 SKIN LACERATION 29 0.0027
168 NEUTROPENIC SEPSIS 19 0.0027
169 FULL BLOOD COUNT ABNORMAL 28 0.0026
170 APPLICATION SITE SWELLING 13 0.0026
171 APPLICATION SITE PAIN 57 0.0026
172 BONE DISORDER 47 0.0026
173 ARTERIOSCLEROSIS 24 0.0025
174 CARDIAC MURMUR 22 0.0025
175 MULTIPLE INJURIES 16 0.0025
176 DRY SKIN 338 0.0025
177 FURUNCLE 20 0.0025
178 DIVERTICULUM INTESTINAL 11 0.0025
179 THERAPY PARTIAL RESPONDER 39 0.0025
180 HYPOKALAEMIA 115 0.0025
181 BLOOD TESTOSTERONE DECREASED 17 0.0025
182 NOCTURIA 30 0.0025
183 DERMATITIS ACNEIFORM 15 0.0025
184 DENTAL CARIES 27 0.0024
185 ARTHROPOD BITE 18 0.0024
186 NERVE INJURY 27 0.0024
187 APPLICATION SITE EXFOLIATION 10 0.0024
188 COMPRESSION FRACTURE 13 0.0024
189 ELECTROLYTE IMBALANCE 28 0.0024
190 EYE DISCHARGE 25 0.0024
191 TRICUSPID VALVE INCOMPETENCE 19 0.0024
192 DRUG INTERACTION 379 0.0024
193 ATELECTASIS 23 0.0024
194 NODULE 31 0.0024
195 MUSCLE FATIGUE 10 0.0024
196 TOOTH INFECTION 31 0.0023
197 RENAL FAILURE CHRONIC 18 0.0023
198 LEFT VENTRICULAR HYPERTROPHY 10 0.0023
199 PERIPHERAL VASCULAR DISORDER 12 0.0023
200 ONYCHOCLASIS 16 0.0023
201 ACUTE KIDNEY INJURY 355 0.0023
202 METASTASES TO BONE 38 0.0023
203 HAIR GROWTH ABNORMAL 16 0.0023
204 SENSITIVE SKIN 17 0.0023
205 RENAL INJURY 68 0.0023
206 THERAPEUTIC RESPONSE SHORTENED 75 0.0023
207 TOOTH ABSCESS 23 0.0023
208 THERAPEUTIC RESPONSE UNEXPECTED 101 0.0022
209 INFUSION SITE EXTRAVASATION 14 0.0022
210 PRURITUS 863 0.0022
211 FOOD POISONING 12 0.0022
212 MENINGITIS ASEPTIC 10 0.0022
213 PRODUCT RESIDUE PRESENT 12 0.0022
214 ERECTILE DYSFUNCTION 57 0.0022
215 PSEUDOMONAS INFECTION 19 0.0022
216 OSTEOMYELITIS 40 0.0022
217 SKIN ULCER 57 0.0022
218 FOLLICULITIS 23 0.0022
219 TUBULOINTERSTITIAL NEPHRITIS 41 0.0022
220 PRODUCT USE IN UNAPPROVED INDICATION 542 0.0022
221 ORAL DISORDER 16 0.0022
222 ORTHOSTATIC HYPOTENSION 38 0.0022
223 RHABDOMYOLYSIS 91 0.0022
224 JOINT EFFUSION 15 0.0022
225 INCREASED TENDENCY TO BRUISE 20 0.0022
226 BONE DENSITY DECREASED 68 0.0022
227 CELLULITIS 109 0.0022
228 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 19 0.0021
229 CONTRAINDICATED PRODUCT ADMINISTERED 65 0.0021
230 PRODUCT COLOUR ISSUE 11 0.0021
231 HYDRONEPHROSIS 16 0.0021
232 INFUSION SITE ERYTHEMA 18 0.0021
233 DECREASED ACTIVITY 23 0.0021
234 EYE INFECTION 24 0.0021
235 HAND FRACTURE 15 0.0021
236 BASAL CELL CARCINOMA 33 0.0021
237 BRAIN FOG 33 0.0021
238 BREAST MASS 14 0.0021
239 PATHOGEN RESISTANCE 19 0.0021
240 FOOD ALLERGY 16 0.0021
241 APPLICATION SITE PRURITUS 47 0.0021
242 CONCUSSION 16 0.0021
243 INFUSION SITE SWELLING 13 0.0021
244 SLUGGISHNESS 21 0.0021
245 BACTERIAL INFECTION 38 0.0020
246 ROTATOR CUFF SYNDROME 26 0.0020
247 LYMPHOEDEMA 14 0.0020
248 ANEURYSM 10 0.0020
249 OBSESSIVE-COMPULSIVE DISORDER 16 0.0020
250 EXOSTOSIS 18 0.0020
251 PAIN OF SKIN 53 0.0020
252 BLOOD SODIUM DECREASED 37 0.0020
253 OSTEOARTHRITIS 83 0.0020
254 URINARY INCONTINENCE 58 0.0020
255 MENISCUS INJURY 12 0.0019
256 RIB FRACTURE 40 0.0019
257 MITRAL VALVE INCOMPETENCE 22 0.0019
258 POST-TRAUMATIC STRESS DISORDER 13 0.0019
259 SCAR 33 0.0019
260 LUNG INFILTRATION 17 0.0019
261 HOSPICE CARE 19 0.0019
262 LIGAMENT SPRAIN 19 0.0019
263 OSTEOPOROSIS 79 0.0019
264 MAJOR DEPRESSION 14 0.0019
265 MOUTH SWELLING 11 0.0019
266 LOCALISED INFECTION 46 0.0019
267 FOOT FRACTURE 36 0.0019
268 RED BLOOD CELL SEDIMENTATION RATE INCREASED 21 0.0019
269 ECCHYMOSIS 13 0.0019
270 HYPOPHOSPHATAEMIA 14 0.0019
271 BLOOD ALKALINE PHOSPHATASE INCREASED 47 0.0019
272 CONJUNCTIVITIS 35 0.0019
273 GINGIVAL PAIN 15 0.0019
274 RASH ERYTHEMATOUS 90 0.0019
275 SUPRAVENTRICULAR TACHYCARDIA 18 0.0019
276 HYPERCHOLESTEROLAEMIA 18 0.0019
277 SINUS BRADYCARDIA 18 0.0019
278 CYST 23 0.0019
279 ERYTHEMA OF EYELID 10 0.0018
280 DRY EYE 92 0.0018
281 DECUBITUS ULCER 15 0.0018
282 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 96 0.0018
283 THERMAL BURN 13 0.0018
284 EOSINOPHILIA 32 0.0018
285 DRUG EFFECT LESS THAN EXPECTED 27 0.0018
286 HAIR DISORDER 15 0.0018
287 INJECTION SITE VESICLES 11 0.0018
288 PULMONARY MASS 27 0.0018
289 ANKLE FRACTURE 28 0.0018
290 THERAPY NON-RESPONDER 81 0.0018
291 RASH MACULAR 63 0.0018
292 MUSCULOSKELETAL DISCOMFORT 31 0.0018
293 HAEMORRHOIDS 35 0.0018
294 PNEUMOCYSTIS JIROVECII PNEUMONIA 18 0.0018
295 SURGERY 105 0.0018
296 EYE PRURITUS 60 0.0018
297 RASH PUSTULAR 13 0.0018
298 POSTOPERATIVE WOUND INFECTION 12 0.0018
299 RASH PRURITIC 96 0.0018
300 APPLICATION SITE IRRITATION 22 0.0018
301 EAR INFECTION 47 0.0018
302 MOUTH ULCERATION 37 0.0018
303 ATRIAL FLUTTER 14 0.0018
304 MICTURITION URGENCY 20 0.0017
305 RASH 762 0.0017
306 PHOTOPSIA 11 0.0017
307 INTERVERTEBRAL DISC PROTRUSION 38 0.0017
308 OSTEONECROSIS OF JAW 43 0.0017
309 VENTRICULAR EXTRASYSTOLES 18 0.0017
310 VITREOUS FLOATERS 17 0.0017
311 PETECHIAE 18 0.0017
312 FORMICATION 12 0.0017
313 SKIN DISCOLOURATION 79 0.0017
314 ERYTHEMA 353 0.0017
315 ALOPECIA 337 0.0017
316 GASTROOESOPHAGEAL REFLUX DISEASE 138 0.0017
317 HICCUPS 14 0.0017
318 PHOTOSENSITIVITY REACTION 28 0.0017
319 OBESITY 27 0.0017
320 GLUCOSE TOLERANCE IMPAIRED 10 0.0017
321 ORAL HERPES 33 0.0017
322 SENSORY DISTURBANCE 27 0.0017
323 LOW DENSITY LIPOPROTEIN INCREASED 13 0.0017
324 BURNING SENSATION 117 0.0017
325 BONE LOSS 25 0.0017
326 BLOOD POTASSIUM INCREASED 27 0.0017
327 HEPATITIS CHOLESTATIC 10 0.0017
328 BIPOLAR DISORDER 18 0.0017
329 PERIPHERAL SWELLING 255 0.0017
330 EYE PAIN 93 0.0016
331 ATRIOVENTRICULAR BLOCK COMPLETE 11 0.0016
332 QUALITY OF LIFE DECREASED 22 0.0016
333 CHROMATURIA 37 0.0016
334 VITAMIN D DECREASED 14 0.0016
335 INFUSION SITE PAIN 21 0.0016
336 SINUS CONGESTION 22 0.0016
337 HYPERKALAEMIA 57 0.0016
338 FEELING DRUNK 12 0.0016
339 PHARYNGITIS 20 0.0016
340 URINARY TRACT INFECTION 275 0.0016
341 TREATMENT FAILURE 133 0.0016
342 TOOTHACHE 29 0.0016
343 SECRETION DISCHARGE 20 0.0016
344 DROOLING 11 0.0016
345 ARTHRITIS 125 0.0016
346 EMPHYSEMA 16 0.0016
347 ADVERSE DRUG REACTION 142 0.0016
348 AORTIC ANEURYSM 12 0.0016
349 DRUG LEVEL INCREASED 26 0.0016
350 NEPHROLITHIASIS 72 0.0016
351 EMOTIONAL DISTRESS 190 0.0016
352 BOWEL MOVEMENT IRREGULARITY 12 0.0016
353 NEOPLASM 18 0.0016
354 OCULAR HYPERAEMIA 74 0.0016
355 GLAUCOMA 30 0.0016
356 LIVER FUNCTION TEST ABNORMAL 45 0.0015
357 INCOHERENT 10 0.0015
358 CARDIOMEGALY 19 0.0015
359 HYPOALBUMINAEMIA 12 0.0015
360 INTENTIONAL DOSE OMISSION 44 0.0015
361 SPINAL OPERATION 19 0.0015
362 TOOTH FRACTURE 17 0.0015
363 APPLICATION SITE VESICLES 10 0.0015
364 PHOTOPHOBIA 29 0.0015
365 CYSTITIS 49 0.0015
366 PULMONARY HAEMORRHAGE 12 0.0015
367 PHARYNGEAL SWELLING 15 0.0015
368 POOR QUALITY SLEEP 33 0.0015
369 RENAL FAILURE ACUTE 65 0.0015
370 BLISTER 86 0.0015
371 DRUG-INDUCED LIVER INJURY 48 0.0015
372 BLOOD POTASSIUM DECREASED 46 0.0015
373 DEAFNESS 40 0.0015
374 APPLICATION SITE ERYTHEMA 40 0.0015
375 PNEUMONIA BACTERIAL 14 0.0015
376 COVID-19 PNEUMONIA 18 0.0015
377 MENTAL STATUS CHANGES 42 0.0015
378 DERMATITIS ALLERGIC 19 0.0015
379 LIMB INJURY 41 0.0015
380 PRODUCT DISTRIBUTION ISSUE 14 0.0015
381 ASPARTATE AMINOTRANSFERASE INCREASED 80 0.0015
382 BODY HEIGHT DECREASED 16 0.0015
383 UPPER RESPIRATORY TRACT INFECTION 69 0.0015
384 SQUAMOUS CELL CARCINOMA 14 0.0015
385 DYSPNOEA EXERTIONAL 56 0.0015
386 RESTLESS LEGS SYNDROME 27 0.0015
387 TOOTH DISORDER 33 0.0015
388 NEUROPATHY PERIPHERAL 141 0.0015
389 MUSCULAR WEAKNESS 168 0.0015
390 SUNBURN 11 0.0015
391 SINUSITIS 151 0.0015
392 PRODUCT PACKAGING ISSUE 14 0.0015
393 HYPOTHYROIDISM 47 0.0015
394 ABNORMAL LOSS OF WEIGHT 10 0.0015
395 ANXIETY 417 0.0015
396 OESOPHAGITIS 16 0.0015
397 INITIAL INSOMNIA 15 0.0015
398 OEDEMA 79 0.0015
399 STAPHYLOCOCCAL INFECTION 48 0.0015
400 MYOSITIS 13 0.0014
401 IRRITABLE BOWEL SYNDROME 31 0.0014
402 SCIATICA 23 0.0014
403 EAR PAIN 28 0.0014
404 HYPERTRANSAMINASAEMIA 10 0.0014
405 HEPATIC CIRRHOSIS 27 0.0014
406 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 69 0.0014
407 AUTOIMMUNE DISORDER 14 0.0014
408 OSTEONECROSIS 47 0.0014
409 ORAL PAIN 32 0.0014
410 PRODUCTIVE COUGH 68 0.0014
411 CANDIDA INFECTION 24 0.0014
412 BRONCHITIS 105 0.0014
413 SWELLING FACE 92 0.0014
414 PAIN IN JAW 40 0.0014
415 HAEMATOCRIT DECREASED 28 0.0014
416 BLOOD CREATININE INCREASED 92 0.0014
417 NERVE COMPRESSION 13 0.0014
418 IRON DEFICIENCY ANAEMIA 13 0.0014
419 HEPATITIS 36 0.0014
420 CHOLELITHIASIS 46 0.0014
421 BURSITIS 17 0.0014
422 TRANSAMINASES INCREASED 31 0.0014
423 BLOOD MAGNESIUM DECREASED 12 0.0014
424 PSYCHOLOGICAL TRAUMA 12 0.0014
425 EYE IRRITATION 80 0.0014
426 PNEUMOTHORAX 22 0.0014
427 VASCULITIS 16 0.0014
428 SPINAL DISORDER 13 0.0014
429 GASTROENTERITIS 20 0.0014
430 CONDITION AGGRAVATED 416 0.0014
431 SKIN BURNING SENSATION 98 0.0014
432 POLLAKIURIA 57 0.0014
433 HALLUCINATION 103 0.0014
434 SENSORY LOSS 11 0.0014
435 NIGHT SWEATS 44 0.0014
436 NEURALGIA 33 0.0014
437 TEMPERATURE INTOLERANCE 14 0.0014
438 BLINDNESS TRANSIENT 10 0.0014
439 ALANINE AMINOTRANSFERASE INCREASED 83 0.0014
440 LIVER FUNCTION TEST INCREASED 29 0.0013
441 TOOTH LOSS 28 0.0013
442 GALLBLADDER DISORDER 24 0.0013
443 ABNORMAL FAECES 11 0.0013
444 HEPATIC STEATOSIS 25 0.0013
445 DEPRESSION 305 0.0013
446 HOT FLUSH 101 0.0013
447 PRODUCT DOSE OMISSION ISSUE 393 0.0013
448 ANAL INCONTINENCE 12 0.0013
449 DYSPHONIA 78 0.0013
450 SLEEP DISORDER 94 0.0013
451 INJECTION SITE DISCOMFORT 14 0.0013
452 RHINORRHOEA 86 0.0013
453 HYPOAESTHESIA ORAL 20 0.0013
454 HYPERSOMNIA 38 0.0013
455 JOINT DISLOCATION 14 0.0013
456 LACRIMATION INCREASED 40 0.0013
457 LIP DRY 12 0.0013
458 HIATUS HERNIA 17 0.0013
459 NO THERAPEUTIC RESPONSE 16 0.0013
460 NASAL CONGESTION 77 0.0013
461 MIGRAINE 125 0.0013
462 PRODUCT DOSE OMISSION IN ERROR 37 0.0013
463 PRODUCT DOSE OMISSION 85 0.0013
464 SMALL INTESTINAL OBSTRUCTION 16 0.0013
465 OFF LABEL USE 1136 0.0013
466 CARDIAC FAILURE CONGESTIVE 104 0.0013
467 RASH PAPULAR 29 0.0013
468 ORAL CANDIDIASIS 17 0.0013
469 HYPOPHAGIA 33 0.0013
470 COORDINATION ABNORMAL 18 0.0013
471 APHTHOUS ULCER 10 0.0013
472 CARPAL TUNNEL SYNDROME 18 0.0013
473 TASTE DISORDER 26 0.0013
474 INJECTION SITE DISCOLOURATION 16 0.0013
475 EYE DISORDER 42 0.0013
476 ARTHRALGIA 531 0.0013
477 DYSURIA 47 0.0013
478 ELECTROCARDIOGRAM ABNORMAL 10 0.0013
479 BALANCE DISORDER 110 0.0013
480 PRODUCT USE COMPLAINT 20 0.0013
481 EAR DISCOMFORT 13 0.0013
482 ACNE 96 0.0013
483 FOOT DEFORMITY 14 0.0013
484 LIMB DISCOMFORT 39 0.0013
485 BLOOD PRESSURE ABNORMAL 25 0.0013
486 HEPATIC CYTOLYSIS 16 0.0013
487 CORONARY ARTERY DISEASE 38 0.0013
488 ACUTE MYOCARDIAL INFARCTION 37 0.0013
489 THERAPEUTIC RESPONSE DECREASED 76 0.0013
490 ELECTROCARDIOGRAM QT PROLONGED 45 0.0012
491 ASTHMA 141 0.0012
492 OCULAR DISCOMFORT 14 0.0012
493 FISTULA 14 0.0012
494 DRY MOUTH 101 0.0012
495 INSURANCE ISSUE 19 0.0012
496 OROPHARYNGEAL PAIN 115 0.0012
497 REBOUND EFFECT 14 0.0012
498 DIZZINESS POSTURAL 12 0.0012
499 PHARYNGEAL OEDEMA 19 0.0012
500 FIBROMYALGIA 30 0.0012
501 FACIAL PAIN 11 0.0012
502 OEDEMA PERIPHERAL 150 0.0012
503 PLATELET COUNT INCREASED 16 0.0012
504 GASTROINTESTINAL INFECTION 11 0.0012
505 CLOSTRIDIUM DIFFICILE COLITIS 13 0.0012
506 DELUSION 19 0.0012
507 BLOOD CHOLESTEROL INCREASED 57 0.0012
508 TINNITUS 56 0.0012
509 CARDIOMYOPATHY 18 0.0012
510 OROPHARYNGEAL DISCOMFORT 11 0.0012
511 HEPATIC ENZYME INCREASED 83 0.0012
512 TREMOR 202 0.0012
513 SWOLLEN TONGUE 38 0.0012
514 MASS 17 0.0012
515 WOUND 34 0.0012
516 GENERALISED OEDEMA 15 0.0012
517 METASTASES TO LUNG 14 0.0012
518 ILEUS 15 0.0012
519 SKIN REACTION 17 0.0012
520 CONSTIPATION 263 0.0012
521 OVARIAN CYST 12 0.0012
522 PULMONARY FIBROSIS 23 0.0012
523 FALL 399 0.0012
524 ACUTE RESPIRATORY FAILURE 23 0.0012
525 SPINAL PAIN 14 0.0012
526 MALIGNANT MELANOMA 16 0.0012
527 PRODUCT PRESCRIBING ISSUE 26 0.0012
528 UROSEPSIS 11 0.0012
529 DEHYDRATION 159 0.0012
530 PRODUCT USE ISSUE 224 0.0012
531 ABSCESS 19 0.0012
532 PRODUCT PHYSICAL ISSUE 24 0.0012
533 WEIGHT DECREASED 332 0.0012
534 TOXIC EPIDERMAL NECROLYSIS 18 0.0012
535 BLOOD BILIRUBIN INCREASED 32 0.0012
536 ILLNESS 122 0.0012
537 IMPAIRED QUALITY OF LIFE 17 0.0012
538 BLOOD IRON DECREASED 14 0.0012
539 GASTRITIS 31 0.0012
540 OXYGEN SATURATION DECREASED 66 0.0012
541 FLANK PAIN 11 0.0012
542 GOUT 21 0.0012
543 BACK DISORDER 19 0.0012
544 WRIST FRACTURE 14 0.0012
545 DRUG RESISTANCE 30 0.0012
546 THYROID DISORDER 18 0.0012
547 HYPOXIA 41 0.0012
548 DISABILITY 23 0.0012
549 INFECTION 168 0.0012
550 CATARACT 69 0.0012
551 INTERNATIONAL NORMALISED RATIO INCREASED 33 0.0012
552 PROTEINURIA 22 0.0012
553 SEPTIC SHOCK 50 0.0011
554 COAGULOPATHY 19 0.0011
555 MUSCLE SPASTICITY 14 0.0011
556 HAEMATURIA 39 0.0011
557 URINARY RETENTION 38 0.0011
558 IMMUNE SYSTEM DISORDER 15 0.0011
559 CHOLECYSTECTOMY 13 0.0011
560 HALLUCINATION, VISUAL 24 0.0011
561 BACK PAIN 263 0.0011
562 HERPES ZOSTER 65 0.0011
563 ACUTE RESPIRATORY DISTRESS SYNDROME 20 0.0011
564 DYSPEPSIA 111 0.0011
565 GAMMA-GLUTAMYLTRANSFERASE INCREASED 25 0.0011
566 DIALYSIS 16 0.0011
567 RETCHING 24 0.0011
568 BREAST PAIN 12 0.0011
569 INFLAMMATION 58 0.0011
570 JOINT INJURY 24 0.0011
571 MUSCLE SPASMS 206 0.0011
572 PNEUMONIA ASPIRATION 28 0.0011
573 RED BLOOD CELL COUNT DECREASED 32 0.0011
574 BODY TEMPERATURE DECREASED 11 0.0011
575 THERAPEUTIC PRODUCT EFFECT DECREASED 50 0.0011
576 COUGH 313 0.0011
577 VERTIGO 68 0.0011
578 INTESTINAL OBSTRUCTION 42 0.0011
579 DIARRHOEA 719 0.0011
580 DRUG INEFFECTIVE 1468 0.0011
581 COGNITIVE DISORDER 52 0.0011
582 SWELLING 104 0.0011
583 MUSCLE TIGHTNESS 18 0.0011
584 SPLENOMEGALY 13 0.0011
585 THROMBOCYTOPENIA 124 0.0011
586 DIZZINESS 553 0.0011
587 FATIGUE 863 0.0011
588 PARANOIA 19 0.0011
589 COVID-19 193 0.0011
590 SALIVARY HYPERSECRETION 11 0.0011
591 CLOSTRIDIUM DIFFICILE INFECTION 24 0.0011
592 TRANSIENT ISCHAEMIC ATTACK 37 0.0011
593 IMPAIRED HEALING 36 0.0011
594 EJECTION FRACTION DECREASED 17 0.0011
595 PNEUMONIA 354 0.0011
596 GAIT DISTURBANCE 209 0.0011
597 HEART RATE INCREASED 108 0.0011
598 DYSPHAGIA 103 0.0011
599 LUNG DISORDER 53 0.0011
600 EXPOSURE VIA SKIN CONTACT 28 0.0011
601 EATING DISORDER 23 0.0011
602 LEUKOPENIA 54 0.0011
603 SYNCOPE 108 0.0011
604 DIPLOPIA 28 0.0011
605 LOSS OF CONSCIOUSNESS 138 0.0011
606 RESPIRATORY TRACT INFECTION 28 0.0011
607 ERYTHEMA MULTIFORME 10 0.0011
608 HYPOGLYCAEMIA 52 0.0011
609 GASTROINTESTINAL DISORDER 96 0.0011
610 UNEVALUABLE EVENT 81 0.0011
611 SNEEZING 24 0.0011
612 PANIC ATTACK 39 0.0011
613 DEFORMITY 10 0.0011
614 PRESYNCOPE 26 0.0011
615 BEDRIDDEN 14 0.0011
616 THERAPY INTERRUPTED 76 0.0011
617 HEPATIC FAILURE 32 0.0011
618 ASTHENIA 398 0.0011
619 BONE PAIN 62 0.0011
620 HEPATOCELLULAR INJURY 15 0.0011
621 PULMONARY HYPERTENSION 22 0.0011
622 NECK PAIN 59 0.0011
623 HYPOAESTHESIA 158 0.0011
624 HEADACHE 661 0.0011
625 GASTROENTERITIS VIRAL 19 0.0011
626 BRONCHOSPASM 15 0.0011
627 PRODUCT ODOUR ABNORMAL 11 0.0010
628 ANAEMIA 200 0.0010
629 THROAT IRRITATION 47 0.0010
630 LYMPHADENOPATHY 37 0.0010
631 TOOTH EXTRACTION 13 0.0010
632 FLUID RETENTION 53 0.0010
633 CHOLESTASIS 20 0.0010
634 INCONTINENCE 11 0.0010
635 FEEDING DISORDER 21 0.0010
636 MULTIPLE FRACTURES 17 0.0010
637 SEPSIS 115 0.0010
638 MOBILITY DECREASED 74 0.0010
639 VENTRICULAR TACHYCARDIA 17 0.0010
640 JOINT STIFFNESS 27 0.0010
641 PAIN 632 0.0010
642 NEUROTOXICITY 18 0.0010
643 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 185 0.0010
644 RENAL IMPAIRMENT 86 0.0010
645 LIP SWELLING 34 0.0010
646 APPLICATION SITE RASH 14 0.0010
647 HEART RATE IRREGULAR 23 0.0010
648 HEPATOMEGALY 10 0.0010
649 GAIT INABILITY 34 0.0010
650 BLOOD UREA INCREASED 17 0.0010
651 FAECES DISCOLOURED 22 0.0010
652 HYPERSENSITIVITY 188 0.0010
653 BACK INJURY 11 0.0010
654 HEAD INJURY 32 0.0010
655 JOINT SWELLING 122 0.0010
656 DIVERTICULITIS 28 0.0010
657 ORAL DISCOMFORT 14 0.0010
658 HALLUCINATION, AUDITORY 16 0.0010
659 STOMATITIS 61 0.0010
660 HUNGER 14 0.0010
661 HAEMATOMA 26 0.0010
662 JAUNDICE 27 0.0010
663 EPISTAXIS 75 0.0010
664 AGEUSIA 25 0.0010
665 DYSPNOEA 566 0.0010
666 PAIN IN EXTREMITY 294 0.0010
667 BRAIN INJURY 10 0.0010
668 CONTUSION 96 0.0010
669 HEART RATE DECREASED 35 0.0010
670 WHEEZING 59 0.0010
671 EYE SWELLING 37 0.0010
672 MYALGIA 169 0.0010
673 CHEST PAIN 184 0.0010
674 FULL BLOOD COUNT DECREASED 20 0.0010
675 DISEASE PROGRESSION 117 0.0010
676 SYSTEMIC LUPUS ERYTHEMATOSUS 35 0.0010
677 PARAESTHESIA 155 0.0010
678 DYSKINESIA 40 0.0010
679 VISION BLURRED 135 0.0010
680 TYPE 2 DIABETES MELLITUS 33 0.0010
681 INSOMNIA 260 0.0010
682 HYPERCALCAEMIA 12 0.0010
683 LYMPHOMA 15 0.0010
684 FEELING COLD 27 0.0010
685 LIVER DISORDER 43 0.0010
686 BLOOD PRESSURE INCREASED 148 0.0010
687 HAEMOPTYSIS 27 0.0010
688 IMPAIRED DRIVING ABILITY 11 0.0010
689 MIDDLE INSOMNIA 18 0.0010
690 SOMNOLENCE 194 0.0010
691 THROAT TIGHTNESS 26 0.0010
692 HEAD DISCOMFORT 17 0.0010
693 TACHYCARDIA 85 0.0010
694 DYSARTHRIA 36 0.0010
695 MOOD ALTERED 26 0.0010
696 INJURY 67 0.0010
697 PLEURAL EFFUSION 58 0.0010
698 VISUAL IMPAIRMENT 118 0.0010
699 DISCOMFORT 58 0.0009
700 INFLUENZA 106 0.0009
701 NAUSEA 752 0.0009
702 DRUG ADMINISTERED AT INAPPROPRIATE SITE 10 0.0009
703 BLOOD PRESSURE DECREASED 63 0.0009
704 GASTRIC ULCER 18 0.0009
705 ATRIAL FIBRILLATION 92 0.0009
706 DIABETES MELLITUS 72 0.0009
707 HYPERTENSION 200 0.0009
708 NASOPHARYNGITIS 174 0.0009
709 ULCER 15 0.0009
710 BRADYCARDIA 50 0.0009
711 LEUKOCYTOSIS 17 0.0009
712 IMMUNODEFICIENCY 14 0.0009
713 ABDOMINAL DISTENSION 98 0.0009
714 ARTHROPATHY 52 0.0009
715 MYDRIASIS 12 0.0009
716 DYSTONIA 18 0.0009
717 MUSCULOSKELETAL STIFFNESS 81 0.0009
718 CHOLECYSTITIS 11 0.0009
719 BLOOD PRESSURE SYSTOLIC INCREASED 18 0.0009
720 TARDIVE DYSKINESIA 26 0.0009
721 LYMPHOPENIA 13 0.0009
722 DECREASED APPETITE 213 0.0009
723 FLATULENCE 52 0.0009
724 PALPITATIONS 107 0.0009
725 MUSCLE TWITCHING 21 0.0009
726 PULMONARY CONGESTION 12 0.0009
727 MEMORY IMPAIRMENT 125 0.0009
728 CONFUSIONAL STATE 147 0.0009
729 ABNORMAL BEHAVIOUR 36 0.0009
730 DEEP VEIN THROMBOSIS 59 0.0009
731 URTICARIA 152 0.0009
732 AMNESIA 59 0.0009
733 SUICIDAL IDEATION 83 0.0009
734 GENERALISED TONIC-CLONIC SEIZURE 15 0.0009
735 MUSCULOSKELETAL CHEST PAIN 14 0.0009
736 MOVEMENT DISORDER 29 0.0009
737 SEIZURE 104 0.0009
738 ABDOMINAL DISCOMFORT 151 0.0009
739 MENTAL DISORDER 39 0.0009
740 COMPLICATION ASSOCIATED WITH DEVICE 13 0.0009
741 HAEMOGLOBIN DECREASED 91 0.0009
742 WHITE BLOOD CELL COUNT INCREASED 34 0.0009
743 POST PROCEDURAL COMPLICATION 17 0.0009
744 WEIGHT INCREASED 198 0.0009
745 HYPERGLYCAEMIA 32 0.0009
746 MUSCULOSKELETAL PAIN 46 0.0009
747 TREATMENT NONCOMPLIANCE 48 0.0009
748 BLOOD PRESSURE FLUCTUATION 21 0.0009
749 CENTRAL NERVOUS SYSTEM LESION 12 0.0009
750 DEPRESSED MOOD 46 0.0009
751 RESPIRATORY DISTRESS 24 0.0009
752 DRUG INTOLERANCE 84 0.0009
753 LETHARGY 50 0.0009
754 KIDNEY INFECTION 17 0.0009
755 BLOOD GLUCOSE ABNORMAL 16 0.0009
756 PULMONARY EMBOLISM 82 0.0009
757 HYPOMAGNESAEMIA 12 0.0009
758 APHONIA 12 0.0009
759 THINKING ABNORMAL 16 0.0009
760 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 20 0.0009
761 HYPOTENSION 171 0.0009
762 COLD SWEAT 15 0.0009
763 MANIA 14 0.0009
764 LYMPHOCYTE COUNT DECREASED 15 0.0008
765 SINUS TACHYCARDIA 12 0.0008
766 DEVICE RELATED INFECTION 13 0.0008
767 FEBRILE NEUTROPENIA 56 0.0008
768 BLOOD URINE PRESENT 16 0.0008
769 VIRAL INFECTION 28 0.0008
770 PRODUCT ADMINISTRATION ERROR 17 0.0008
771 MUCOSAL INFLAMMATION 22 0.0008
772 SPEECH DISORDER 44 0.0008
773 THIRST 15 0.0008
774 HYPERHIDROSIS 108 0.0008
775 MACULAR DEGENERATION 10 0.0008
776 SKIN CANCER 18 0.0008
777 BLOOD GLUCOSE DECREASED 40 0.0008
778 GLYCOSYLATED HAEMOGLOBIN INCREASED 21 0.0008
779 PARAESTHESIA ORAL 12 0.0008
780 VOMITING 388 0.0008
781 DEMENTIA 23 0.0008
782 DYSSTASIA 24 0.0008
783 RESPIRATORY TRACT CONGESTION 13 0.0008
784 AGITATION 60 0.0008
785 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 14 0.0008
786 RASH MACULO-PAPULAR 18 0.0008
787 AGRANULOCYTOSIS 15 0.0008
788 INJECTION SITE PRURITUS 54 0.0008
789 CORONARY ARTERY OCCLUSION 11 0.0008
790 PRESCRIBED UNDERDOSE 16 0.0008
791 CHEST DISCOMFORT 82 0.0008
792 INTENTIONAL PRODUCT USE ISSUE 70 0.0008
793 SPINAL FRACTURE 16 0.0008
794 ABNORMAL DREAMS 22 0.0008
795 INJECTION SITE SWELLING 61 0.0008
796 RENAL DISORDER 37 0.0008
797 FRACTURE 15 0.0008
798 ABDOMINAL PAIN UPPER 163 0.0008
799 DRUG ERUPTION 14 0.0008
800 MUSCLE ATROPHY 10 0.0008
801 FEELING JITTERY 15 0.0008
802 PSYCHOMOTOR HYPERACTIVITY 13 0.0008
803 INTRAOCULAR PRESSURE INCREASED 10 0.0008
804 ABDOMINAL PAIN 182 0.0008
805 BLINDNESS UNILATERAL 11 0.0008
806 HIP FRACTURE 25 0.0008
807 ACCIDENTAL EXPOSURE TO PRODUCT 80 0.0008
808 ANOREXIA 10 0.0008
809 TENDONITIS 12 0.0008
810 LIVER INJURY 19 0.0008
811 UPPER GASTROINTESTINAL HAEMORRHAGE 13 0.0008
812 RASH GENERALISED 20 0.0008
813 THROMBOSIS 62 0.0008
814 PELVIC PAIN 14 0.0008
815 RESPIRATORY FAILURE 56 0.0008
816 FEELING ABNORMAL 184 0.0008
817 GASTROINTESTINAL HAEMORRHAGE 64 0.0008
818 RESTLESSNESS 28 0.0008
819 INJECTION SITE BRUISING 61 0.0008
820 KNEE ARTHROPLASTY 16 0.0008
821 CARDIAC DISORDER 71 0.0008
822 ACTIVITIES OF DAILY LIVING IMPAIRED 15 0.0008
823 FEELING HOT 46 0.0007
824 INJECTION SITE PAIN 230 0.0007
825 HYPOCALCAEMIA 14 0.0007
826 METASTASES TO LIVER 13 0.0007
827 MALAISE 324 0.0007
828 PYREXIA 255 0.0007
829 HOSPITALISATION 113 0.0007
830 BODY TEMPERATURE INCREASED 15 0.0007
831 PALLOR 20 0.0007
832 ANGINA PECTORIS 21 0.0007
833 GINGIVAL BLEEDING 10 0.0007
834 INJECTION SITE WARMTH 15 0.0007
835 THERAPY CESSATION 37 0.0007
836 METABOLIC ACIDOSIS 23 0.0007
837 CHILLS 84 0.0007
838 DYSGEUSIA 53 0.0007
839 NEUTROPENIA 97 0.0007
840 NEUTROPHIL COUNT DECREASED 29 0.0007
841 ACCIDENTAL OVERDOSE 26 0.0007
842 ADVERSE EVENT 65 0.0007
843 FREQUENT BOWEL MOVEMENTS 19 0.0007
844 UPPER LIMB FRACTURE 14 0.0007
845 RESPIRATORY DISORDER 21 0.0007
846 APHASIA 21 0.0007
847 CARDIO-RESPIRATORY ARREST 29 0.0007
848 INJECTION SITE URTICARIA 17 0.0007
849 INCORRECT PRODUCT ADMINISTRATION DURATION 15 0.0007
850 NERVOUSNESS 36 0.0007
851 DISTURBANCE IN ATTENTION 37 0.0007
852 MALIGNANT NEOPLASM PROGRESSION 70 0.0007
853 DISORIENTATION 27 0.0007
854 INFUSION RELATED REACTION 45 0.0007
855 ANGIOEDEMA 30 0.0007
856 DIABETES MELLITUS INADEQUATE CONTROL 12 0.0007
857 DRUG PRESCRIBING ERROR 13 0.0007
858 HYPOACUSIS 29 0.0007
859 NERVOUS SYSTEM DISORDER 21 0.0007
860 HERNIA 13 0.0007
861 PRODUCT PRESCRIBING ERROR 16 0.0007
862 COLON CANCER 10 0.0007
863 HEPATIC FUNCTION ABNORMAL 25 0.0007
864 PLASMA CELL MYELOMA 26 0.0007
865 WHITE BLOOD CELL COUNT DECREASED 72 0.0007
866 DELIRIUM 23 0.0007
867 EXPIRED PRODUCT ADMINISTERED 22 0.0007
868 COLITIS 25 0.0007
869 PLATELET COUNT DECREASED 70 0.0007
870 IMPAIRED WORK ABILITY 14 0.0007
871 INJECTION SITE ERYTHEMA 81 0.0007
872 BLOOD GLUCOSE INCREASED 123 0.0007
873 ANAPHYLACTIC REACTION 36 0.0007
874 PERICARDIAL EFFUSION 15 0.0006
875 PANCYTOPENIA 36 0.0006
876 WITHDRAWAL SYNDROME 27 0.0006
877 INTENTIONAL PRODUCT MISUSE 56 0.0006
878 MULTIPLE ORGAN DYSFUNCTION SYNDROME 18 0.0006
879 PRODUCT PREPARATION ERROR 13 0.0006
880 FEAR 17 0.0006
881 LOCAL SWELLING 11 0.0006
882 MUSCULOSKELETAL DISORDER 12 0.0006
883 STEVENS-JOHNSON SYNDROME 14 0.0006
884 BLOOD CREATINE PHOSPHOKINASE INCREASED 18 0.0006
885 LOWER LIMB FRACTURE 12 0.0006
886 PANCREATITIS 33 0.0006
887 HYPONATRAEMIA 35 0.0006
888 ENCEPHALOPATHY 15 0.0006
889 PRURITUS GENERALISED 13 0.0006
890 CARDIAC ARREST 49 0.0006
891 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 42 0.0006
892 HAEMORRHAGE 61 0.0006
893 INFLUENZA LIKE ILLNESS 48 0.0006
894 DIABETIC KETOACIDOSIS 14 0.0006
895 GASTRIC DISORDER 20 0.0006
896 IRRITABILITY 35 0.0006
897 GYNAECOMASTIA 18 0.0006
898 HAEMATOCHEZIA 32 0.0006
899 PERITONITIS 12 0.0006
900 NIGHTMARE 20 0.0006
901 MENTAL IMPAIRMENT 14 0.0006
902 C-REACTIVE PROTEIN INCREASED 21 0.0006
903 PSYCHOTIC DISORDER 17 0.0006
904 DRUG EFFECT DECREASED 31 0.0006
905 ROAD TRAFFIC ACCIDENT 24 0.0006
906 MATERNAL EXPOSURE DURING PREGNANCY 51 0.0006
907 ARRHYTHMIA 27 0.0006
908 ERUCTATION 11 0.0006
909 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 115 0.0006
910 CHOKING 11 0.0006
911 GENERAL PHYSICAL HEALTH DETERIORATION 65 0.0006
912 CEREBROVASCULAR ACCIDENT 95 0.0006
913 FLUSHING 57 0.0006
914 RECTAL HAEMORRHAGE 24 0.0006
915 PULMONARY OEDEMA 25 0.0006
916 ABDOMINAL PAIN LOWER 14 0.0006
917 PNEUMONITIS 15 0.0006
918 INTENTIONAL SELF-INJURY 11 0.0005
919 GLOSSODYNIA 12 0.0005
920 INCORRECT DOSE ADMINISTERED 122 0.0005
921 PANCREATITIS ACUTE 12 0.0005
922 PRODUCT AVAILABILITY ISSUE 12 0.0005
923 ABASIA 13 0.0005
924 EXTRAPYRAMIDAL DISORDER 13 0.0005
925 PRODUCT QUALITY ISSUE 71 0.0005
926 INJECTION SITE RASH 16 0.0005
927 AGGRESSION 26 0.0005
928 EMOTIONAL DISORDER 16 0.0005
929 HAEMATEMESIS 13 0.0005
930 RHEUMATOID ARTHRITIS 58 0.0005
931 MULTIPLE SCLEROSIS RELAPSE 35 0.0005
932 LABORATORY TEST ABNORMAL 15 0.0005
933 PRODUCT DISPENSING ERROR 11 0.0005
934 SEDATION 13 0.0005
935 INJECTION SITE REACTION 34 0.0005
936 UNDERDOSE 36 0.0005
937 EXPOSURE DURING PREGNANCY 30 0.0005
938 ASCITES 14 0.0005
939 ANGER 16 0.0005
940 CONVULSION 27 0.0005
941 DRUG DOSE OMISSION 77 0.0005
942 NEOPLASM MALIGNANT 31 0.0005
943 DISEASE RECURRENCE 22 0.0005
944 MULTIPLE SCLEROSIS 22 0.0005
945 NEOPLASM PROGRESSION 16 0.0005
946 INJECTION SITE MASS 17 0.0005
947 EPILEPSY 14 0.0005
948 PROSTATE CANCER 36 0.0004
949 COLITIS ULCERATIVE 20 0.0004
950 DEVICE ISSUE 40 0.0004
951 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 13 0.0004
952 LUNG NEOPLASM MALIGNANT 18 0.0004
953 VAGINAL HAEMORRHAGE 19 0.0004
954 DEATH 376 0.0004
955 CARDIAC FAILURE 35 0.0004
956 MYOCARDIAL INFARCTION 76 0.0004
957 ABORTION SPONTANEOUS 17 0.0004
958 FEMUR FRACTURE 13 0.0004
959 EXTRA DOSE ADMINISTERED 17 0.0004
960 DRUG EFFECT INCOMPLETE 15 0.0004
961 CRYING 15 0.0004
962 ILL-DEFINED DISORDER 24 0.0004
963 CARDIOVASCULAR DISORDER 10 0.0004
964 INCORRECT DRUG ADMINISTRATION DURATION 11 0.0004
965 CEREBRAL HAEMORRHAGE 14 0.0004
966 ANAPHYLACTIC SHOCK 10 0.0004
967 PRODUCT SUBSTITUTION ISSUE 22 0.0004
968 SUICIDE ATTEMPT 23 0.0004
969 NEEDLE ISSUE 11 0.0004
970 VISUAL ACUITY REDUCED 12 0.0004
971 DEPRESSED LEVEL OF CONSCIOUSNESS 14 0.0004
972 NO ADVERSE EVENT 64 0.0004
973 DRUG EXPOSURE DURING PREGNANCY 12 0.0004
974 LOWER RESPIRATORY TRACT INFECTION 16 0.0004
975 MOOD SWINGS 11 0.0003
976 INJECTION SITE HAEMORRHAGE 26 0.0003
977 BLINDNESS 12 0.0003
978 INTERSTITIAL LUNG DISEASE 14 0.0003
979 DEVICE MALFUNCTION 20 0.0003
980 DEVICE LEAKAGE 11 0.0003
981 TOXICITY TO VARIOUS AGENTS 41 0.0002
982 OVERDOSE 52 0.0002
983 MEDICATION ERROR 13 0.0002
984 PRODUCT STORAGE ERROR 19 0.0002
985 BREAST CANCER 18 0.0002
986 INTENTIONAL OVERDOSE 12 0.0002
987 DRUG WITHDRAWAL SYNDROME 15 0.0002
988 DRUG DEPENDENCE 24 0.0001
989 FOETAL EXPOSURE DURING PREGNANCY 11 0.0001
990 DRUG DOSE OMISSION BY DEVICE 10 0.0001